Using advanced imaging to detect how aggressive prostate cancer is
Detecting prostate cancer aggressiveness using photoacoustic chemical imaging with photoacoustic spectral analysis
['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11132305
This study is testing a new imaging technique that uses light and tiny probes to help doctors better see and understand aggressive prostate cancer in men, so they can make more accurate diagnoses and treatment choices.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11132305 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the diagnosis of aggressive prostate cancer in American men by developing a new imaging technique. The approach utilizes photoacoustic imaging combined with biocompatible nanoscale probes to enhance the detection and characterization of tumors. By evaluating the chemical environment and microarchitecture of the prostate, this method aims to provide real-time insights that could lead to more accurate diagnoses and better treatment decisions. Patients may benefit from a more precise understanding of their cancer's aggressiveness, which is crucial for effective management.
Who could benefit from this research
Good fit: Ideal candidates for this research are American men who are undergoing evaluation for prostate cancer.
Not a fit: Patients with non-aggressive prostate cancer or those who are not undergoing prostate cancer evaluation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses of prostate cancer aggressiveness, improving treatment outcomes for patients.
How similar studies have performed: Similar approaches using advanced imaging techniques have shown promise in enhancing cancer diagnosis, indicating potential success for this novel method.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JO, JANGGUN — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: JO, JANGGUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: cancer biomarkers, cancer diagnosis